implant rates in 'real world' clinical practice, as well as the relationship with the epidemiology of heart failure are not defined. 
METHODS AND RESULTS

In
CONCLUSIONS
The application in 'real world' clinical practice of CRT in heart failure is quite heterogeneous, with substantial variability even among areas belonging to the same region, with the need to make the access to this treatment more equitable. Despite the increased use of CRT, its overall rate of adoption is low, if a population of prevalent heart failure patients is selected on the basis of administrative data on hospitalizations.
